Scientists have found that drugs for hypertension on the basis of certain substances can cause cancer.
So, researchers from Denmark identified as a dangerous component of valsartan on the basis of which to make such drugs.
According to them, with a long reception of the drug can cause health problems. This may be the result of the purification process in the production of specified antihypertensive agents.
It is noted that a pharmaceutical company Zhejiang Huahai Pharmaceuticals, which manufactures tablets on the basis of these substances has withdrawn from the pharmaceutical market their products.